Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 5 | 2019 | 87 | 0.630 |
Why?
|
| Positron-Emission Tomography | 1 | 2006 | 19 | 0.240 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 27 | 0.220 |
Why?
|
| Barrett Esophagus | 2 | 2015 | 4 | 0.220 |
Why?
|
| Catheter Ablation | 2 | 2015 | 7 | 0.220 |
Why?
|
| Biomarkers, Tumor | 2 | 2014 | 37 | 0.210 |
Why?
|
| Aged | 9 | 2019 | 1860 | 0.200 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2003 | 1 | 0.190 |
Why?
|
| Pleurodesis | 1 | 2003 | 1 | 0.190 |
Why?
|
| Drainage | 1 | 2003 | 18 | 0.190 |
Why?
|
| Female | 10 | 2019 | 3346 | 0.180 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2014 | 37 | 0.180 |
Why?
|
| Male | 8 | 2019 | 3399 | 0.160 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2019 | 5 | 0.150 |
Why?
|
| False Positive Reactions | 1 | 2019 | 14 | 0.150 |
Why?
|
| Unnecessary Procedures | 1 | 2019 | 10 | 0.150 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 29 | 0.150 |
Why?
|
| Neoplasm Staging | 4 | 2019 | 74 | 0.140 |
Why?
|
| Humans | 9 | 2019 | 5837 | 0.130 |
Why?
|
| Middle Aged | 6 | 2015 | 1775 | 0.120 |
Why?
|
| Esophagoscopy | 1 | 2015 | 3 | 0.110 |
Why?
|
| Learning Curve | 1 | 2015 | 2 | 0.110 |
Why?
|
| Esophageal Neoplasms | 1 | 2015 | 7 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2015 | 53 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 11 | 0.110 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2014 | 5 | 0.110 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2014 | 7 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2014 | 25 | 0.100 |
Why?
|
| Prognosis | 3 | 2014 | 138 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2014 | 584 | 0.100 |
Why?
|
| Nitriles | 1 | 2012 | 1 | 0.090 |
Why?
|
| Toxicity Tests | 1 | 2012 | 1 | 0.090 |
Why?
|
| Embryonic Development | 1 | 2012 | 2 | 0.090 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 8 | 0.090 |
Why?
|
| Pyrazoles | 1 | 2012 | 14 | 0.090 |
Why?
|
| Hospitals, Community | 1 | 2011 | 5 | 0.080 |
Why?
|
| Community-Institutional Relations | 1 | 2011 | 6 | 0.080 |
Why?
|
| Medical Oncology | 1 | 2011 | 10 | 0.080 |
Why?
|
| Minority Groups | 1 | 2011 | 16 | 0.080 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 51 | 0.080 |
Why?
|
| Patient Selection | 1 | 2011 | 48 | 0.080 |
Why?
|
| Neoplasms | 1 | 2011 | 39 | 0.080 |
Why?
|
| Thoracotomy | 1 | 2010 | 4 | 0.080 |
Why?
|
| Radiosurgery | 1 | 2010 | 5 | 0.080 |
Why?
|
| Survival Rate | 2 | 2010 | 60 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2014 | 1034 | 0.080 |
Why?
|
| Recurrence | 2 | 2014 | 52 | 0.070 |
Why?
|
| Algorithms | 2 | 2014 | 82 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2015 | 411 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2015 | 601 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 125 | 0.060 |
Why?
|
| Adult | 3 | 2014 | 1670 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 53 | 0.050 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2003 | 1 | 0.050 |
Why?
|
| Catheters, Indwelling | 1 | 2003 | 5 | 0.050 |
Why?
|
| Risk Factors | 2 | 2015 | 499 | 0.050 |
Why?
|
| Length of Stay | 1 | 2003 | 45 | 0.050 |
Why?
|
| United States | 2 | 2015 | 502 | 0.050 |
Why?
|
| Mediastinoscopy | 1 | 2019 | 5 | 0.040 |
Why?
|
| Thoracoscopy | 1 | 2019 | 5 | 0.040 |
Why?
|
| Bronchoscopy | 1 | 2019 | 14 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 25 | 0.040 |
Why?
|
| Pneumonia | 1 | 2019 | 25 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2015 | 3 | 0.030 |
Why?
|
| Hospitals, Low-Volume | 1 | 2015 | 3 | 0.030 |
Why?
|
| Hospitals, High-Volume | 1 | 2015 | 3 | 0.030 |
Why?
|
| Remission Induction | 1 | 2015 | 16 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 64 | 0.030 |
Why?
|
| Registries | 1 | 2015 | 45 | 0.030 |
Why?
|
| Logistic Models | 1 | 2015 | 109 | 0.030 |
Why?
|
| Minnesota | 1 | 2014 | 5 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2014 | 19 | 0.030 |
Why?
|
| ROC Curve | 1 | 2014 | 34 | 0.030 |
Why?
|
| Reoperation | 1 | 2015 | 146 | 0.030 |
Why?
|
| Illinois | 1 | 2014 | 52 | 0.030 |
Why?
|
| Cytokines | 1 | 2014 | 63 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 100 | 0.030 |
Why?
|
| Time Factors | 1 | 2015 | 374 | 0.030 |
Why?
|
| Disease Progression | 1 | 2014 | 157 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 163 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2015 | 154 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 150 | 0.030 |
Why?
|
| Incidence | 1 | 2014 | 165 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 333 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 421 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2012 | 1 | 0.020 |
Why?
|
| Fetus | 1 | 2012 | 8 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2012 | 13 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2012 | 25 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 48 | 0.020 |
Why?
|
| Pregnancy | 1 | 2012 | 103 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2012 | 74 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2012 | 77 | 0.020 |
Why?
|
| Michigan | 1 | 2011 | 4 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2011 | 16 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2011 | 30 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2011 | 17 | 0.020 |
Why?
|
| Mice | 1 | 2012 | 465 | 0.020 |
Why?
|
| Animals | 1 | 2012 | 1349 | 0.020 |
Why?
|